Psyllium Husks

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Psyllium Husks

Administration Routes

UnknownOral

Species Affected

Dog 12
Cat 1

Most Affected Breeds

Chihuahua 3
Retriever - Golden 2
Shepherd Dog - German 2
Pointing Dog - Hungarian Short-haired (Vizsla) 1
Greyhound 1
Shepherd Dog - Australian 1
Siberian Husky 1
Domestic Shorthair 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Most Reported Reactions

Diarrhoea 7
Lethargy (see also Central nervous system depression in Neurological) 4
Neutrophilia 3
Abnormal radiograph finding 3
Decreased appetite 3
Impaired hearing 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy (endoparasite) - hookworm 2
Thrombocytopenia 2
Elevated alanine aminotransferase (ALT) 2
Vomiting 2
Bloody diarrhoea 2

Outcome Breakdown

Outcome Unknown
7 (53.8%)
Ongoing
6 (46.2%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 9
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Psyllium Husks Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Psyllium Husks, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Psyllium Husks. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Psyllium Husks reports are Dog (12 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Chihuahua (3), Retriever - Golden (2), Shepherd Dog - German (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Psyllium Husks are Diarrhoea (7), Lethargy (see also Central nervous system depression in Neurological) (4), Neutrophilia (3), Abnormal radiograph finding (3). Of the 13 reports with a coded outcome, Outcome Unknown is the leading category at 53.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Psyllium Husks.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial